{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:48:52Z","timestamp":1791877732097,"version":"4.3.4"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T00:00:00Z","timestamp":1595203200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Kedrion","award":["This study was sponsored by an unrestricted grant from Kedrion S.p.A. (https:\/\/www.kedrion.com) to IQVIA Solutions Italy S.r.l., which then provided support in the form of salaries for Valeria Pegoraro and Duccio Urbinati. Nonetheless, Kedrion S.p.A. had no role in study design, data collection and analysis, the decision to submit a manuscript for publication, or the preparation or editing of the manuscript."],"award-info":[{"award-number":["This study was sponsored by an unrestricted grant from Kedrion S.p.A. (https:\/\/www.kedrion.com) to IQVIA Solutions Italy S.r.l., which then provided support in the form of salaries for Valeria Pegoraro and Duccio Urbinati. Nonetheless, Kedrion S.p.A. had no role in study design, data collection and analysis, the decision to submit a manuscript for publication, or the preparation or editing of the manuscript."]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0235807","type":"journal-article","created":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T13:31:48Z","timestamp":1595251908000},"page":"e0235807","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":67,"title":["Hemolytic disease of the fetus and newborn due to Rh(D) incompatibility: A preventable disease that still produces significant morbidity and mortality in children"],"prefix":"10.1371","volume":"15","author":[{"given":"Valeria","family":"Pegoraro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ducciocompet","family":"Urbinati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard H. A.","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Carlo","family":"Di Renzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvin","family":"Zipursky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brie A.","family":"Stotler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8528-4561","authenticated-orcid":true,"given":"Steven L.","family":"Spitalnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,7,20]]},"reference":[{"issue":"1","key":"pone.0235807.ref001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/tme.12099","article-title":"Anti\u2010D prophylaxis: past, present and future","volume":"24","author":"M de Haas","year":"2014","journal-title":"Transfusion Medicine"},{"issue":"2","key":"pone.0235807.ref002","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/vox.12265","article-title":"Haemolytic disease of the fetus and newborn","volume":"109","author":"M de Haas","year":"2015","journal-title":"Vox Sanguinis"},{"issue":"4","key":"pone.0235807.ref003","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.tmrv.2016.05.008","article-title":"Hemolytic disease of the fetus and newborn: modern practice and future investigations","volume":"30","author":"JE Hendrickson","year":"2016","journal-title":"Transfusion Medicine Reviews"},{"issue":"1","key":"pone.0235807.ref004","first-page":"8","article-title":"The role of antenatal immunoprophylaxis in the prevention of maternal-foetal anti-Rh (D) alloimmunisation","volume":"8","author":"GM Liumbruno","year":"2010","journal-title":"Blood Transfusion"},{"issue":"3","key":"pone.0235807.ref005","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1537-2995.1968.tb04895.x","article-title":"Results of clinical trials of RhoGAM in women","volume":"9","author":"W Pollack","year":"1968","journal-title":"Transfusion"},{"issue":"7070","key":"pone.0235807.ref006","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0140-6736(59)92264-0","article-title":"Foetal erythrocytes in the maternal circulation","volume":"273","author":"A Zipursky","year":"1959","journal-title":"The Lancet"},{"issue":"1","key":"pone.0235807.ref007","first-page":"109","article-title":"Recommendations for the prevention and treatment of haemolytic disease of the foetus and newborn","volume":"13","author":"F Bennardello","year":"2015","journal-title":"Blood Transfusion"},{"issue":"2","key":"pone.0235807.ref008","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1097\/AOG.0000000000002232","article-title":"ACOG practice bulletin No. 181: Prevention of Rh D alloimmunization. Clinical management guidelines for obstetrician-gynecologists","volume":"130","author":"American College of Obstetricians and Gynecologists","year":"2017","journal-title":"Obstetrics & Gynecology"},{"issue":"1","key":"pone.0235807.ref009","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/tme.12091","article-title":"BCSH guideline for the use of anti\u2010D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn","volume":"24","author":"H Qureshi","year":"2014","journal-title":"Transfusion Medicine"},{"issue":"02","key":"pone.0235807.ref010","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1055\/s-0037-1606609","article-title":"Prevention of RhD alloimmunization: a comparison of four national guidelines","volume":"35","author":"JD Sperling","year":"2018","journal-title":"American Journal of Perinatology"},{"issue":"2","key":"pone.0235807.ref011","doi-asserted-by":"crossref","first-page":"F84","DOI":"10.1136\/adc.2009.181172","article-title":"The global burden of Rh disease","volume":"96","author":"A Zipursky","year":"2011","journal-title":"Archives of Disease in Childhood-Fetal and Neonatal Edition"},{"issue":"4","key":"pone.0235807.ref012","first-page":"518","article-title":"Survey on the prevention and incidence of haemolytic disease of the newborn in Italy","volume":"11","author":"F Bennardello","year":"2013","journal-title":"Blood Transfusion"},{"issue":"S1","key":"pone.0235807.ref013","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/pr.2013.208","article-title":"Neonatal hyperbilirubinemia and Rhesus disease of the newborn: incidence and impairment estimates for 2010 at regional and global levels","volume":"74","author":"VK Bhutani","year":"2013","journal-title":"Pediatric Research"},{"key":"pone.0235807.ref014","volume-title":"A fair chance for every child","author":"K Watkins","year":"2016"},{"key":"pone.0235807.ref015","unstructured":"The World Factbook. Central Intelligence Agency. https:\/\/www.cia.gov\/library\/publications\/the-world-factbook\/. (Accessed July 4, 2018)"},{"issue":"1","key":"pone.0235807.ref016","doi-asserted-by":"crossref","first-page":"e0147955","DOI":"10.1371\/journal.pone.0147955","article-title":"Heterozygote advantage probably maintains Rhesus factor blood group polymorphism: Ecological regression study","volume":"11","author":"J Flegr","year":"2016","journal-title":"PLOS ONE"},{"issue":"4","key":"pone.0235807.ref017","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/j.1475-6773.2008.00838.x","article-title":"Does reimportation reduce price differences for prescription drugs? Lessons from the European Union","volume":"43","author":"MK Kyle","year":"2008","journal-title":"Health Services ResearchAug"},{"issue":"1","key":"pone.0235807.ref018","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1186\/s12913-017-2649-6","article-title":"Variability in market uptake of psychotropic medications in Europe reflects cultural diversity","volume":"17","author":"JM Hoebert","year":"2017","journal-title":"BMC Health Services Research"},{"issue":"2","key":"pone.0235807.ref019","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jval.2016.11.031","article-title":"Concerns around budget impact thresholds: not all drugs are the same","volume":"20","author":"M Ciarametaro","year":"2017","journal-title":"Value in Health"},{"issue":"12","key":"pone.0235807.ref020","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1136\/adc.2004.050468","article-title":"Increased prescribing trends of paediatric psychotropic medications","volume":"89","author":"IC Wong","year":"2004","journal-title":"Archives of Disease in Childhood"},{"issue":"6","key":"pone.0235807.ref021","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1365-2125.2005.02450.x","article-title":"The potential of UK clinical databases in enhancing paediatric medication research","volume":"59","author":"IC Wong","year":"2005","journal-title":"British Journal of Clinical Pharmacology"},{"key":"pone.0235807.ref022","unstructured":"RheDQuin is used to prevent the formation of antibodies against blood type Rhesus D. https:\/\/www.sanquin.org\/products-and-services\/plasma-pharmaceuticals\/products-and-instructions\/immunoglobulines. (Accessed June 21, 2019)."},{"key":"pone.0235807.ref023","unstructured":"WHO recommendation on antenatal anti-D immunoglobulin prophylaxis. https:\/\/extranet.who.int\/rhl\/topics\/preconception-pregnancy-childbirth-and-postpartum-care\/antenatal-care\/who-recommendation-antenatal-anti-d-immunoglobulin-prophylaxis. (Accessed May 19, 2019)"},{"issue":"7","key":"pone.0235807.ref024","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.pathol.2017.08.010","article-title":"Non-invasive fetal RHD genotyping for RhD negative women stratified into RHD gene deletion or variant groups: comparative accuracy using two blood collection tube types","volume":"49","author":"CA Hyland","year":"2017","journal-title":"Pathology"},{"key":"pone.0235807.ref025","article-title":"The continuing burden of Rh disease 50 years after the introduction of anti-Rh (D) immunoglobin prophylaxis; A call to action","volume":"20","author":"GH Visser","year":"2019","journal-title":"American Journal of Obstetrics & Gynecology"},{"issue":"1","key":"pone.0235807.ref026","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1186\/s12884-014-0411-1","article-title":"Appropriate provision of anti-D prophylaxis to RhD negative pregnant women: A scoping review","volume":"14","author":"TM Fyfe","year":"2014","journal-title":"BMC Pregnancy and Childbirth"},{"issue":"6","key":"pone.0235807.ref027","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1111\/trf.14125","article-title":"Obstetrics and gynecology physician knowledge of Rh immune globulin prophylaxis","volume":"57","author":"A Yu","year":"2017","journal-title":"Transfusion"},{"issue":"3","key":"pone.0235807.ref028","doi-asserted-by":"crossref","first-page":"465","DOI":"10.5858\/133.3.465","article-title":"Inaccurate doses of Rh immune globulin after Rh-incompatible fetomaternal hemorrhage: Survey of laboratory practice","volume":"133","author":"G Ramsey","year":"2009","journal-title":"Archives of Pathology & Laboratory MedicineMar"},{"issue":"2","key":"pone.0235807.ref029","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/PAT.0000000000000225","article-title":"Prevalence of maternal red cell alloimmunisation: a population study from Queensland, Australia","volume":"47","author":"M Pal","year":"2015","journal-title":"Pathology"},{"issue":"1","key":"pone.0235807.ref030","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/uog.14723","article-title":"Costs and benefits of non\u2010invasive fetal RhD determination","volume":"45","author":"L Teitelbaum","year":"2015","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"4","key":"pone.0235807.ref031","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/tme.12132","article-title":"A correlation between severe haemolytic disease of the fetus and newborn and maternal ABO blood group","volume":"24","author":"B Doyle","year":"2014","journal-title":"Transfusion Medicine"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0235807","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T22:40:00Z","timestamp":1616712000000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0235807"}},"subtitle":[],"editor":[{"given":"Ju Lee","family":"Oei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,7,20]]},"references-count":31,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0235807","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,20]]}}}